Wormser Freres Gestion’s AstraZeneca AZN Stock Holding History

Wormser Freres Gestion’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$351K	Buy	+2,149	New	+$358K	0.19%	27

Other funds holding AZN

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Wormser Freres Gestion's AZN Position: Q3 2026 in Review

Wormser Freres Gestion opened a new position in AstraZeneca (AZN) in Q3 2026: 2,149 shares worth $351K. The stake represents 0.19% of the portfolio and ranks #27 among its holdings.

380 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Wormser Freres Gestion held 2,149 shares of AstraZeneca worth $351K as of Q3 2026.
AstraZeneca was a new Wormser Freres Gestion position in Q3 2026.
AstraZeneca made up 0.19% of Wormser Freres Gestion's portfolio in Q3 2026, its #27 holding.
380 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Wormser Freres Gestion's 13F filing for Q3 2026, filed 21 Oct 2026.